Literature DB >> 11877464

Apoptosis and NF-kappa B: the FADD connection.

Colin S Duckett1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11877464      PMCID： PMC150897          DOI： 10.1172/JCI15197

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  14 in total

Review 1.  Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity.

Authors:  G Zhang; S Ghosh
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

2.  Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells.

Authors:  F J Schaub; D K Han; W C Liles; L D Adams; S A Coats; R K Ramachandran; R A Seifert; S M Schwartz; D F Bowen-Pope
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

Review 3.  Death receptors couple to both cell proliferation and apoptosis.

Authors:  Ralph C Budd
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

4.  FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.

Authors:  A M Chinnaiyan; K O'Rourke; M Tewari; V M Dixit
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

5.  Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death.

Authors:  Z G Liu; H Hsu; D V Goeddel; M Karin
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

6.  The Fas-associated death domain protein suppresses activation of NF-kappa B by LPS and IL-1 beta.

Authors:  Douglas D Bannerman; Joan C Tupper; James D Kelly; Robert K Winn; John M Harlan
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

7.  Activation of the NF-kappaB pathway by caspase 8 and its homologs.

Authors:  P M Chaudhary; M T Eby; A Jasmin; A Kumar; L Liu; L Hood
Journal:  Oncogene       Date:  2000-09-14       Impact factor: 9.867

8.  Activation of NF-kappaB by FADD, Casper, and caspase-8.

Authors:  W H Hu; H Johnson; H B Shu
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

9.  TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.

Authors:  H Hsu; H B Shu; M G Pan; D V Goeddel
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

Review 10.  Transducers of life and death: TNF receptor superfamily and associated proteins.

Authors:  S J Baker; E P Reddy
Journal:  Oncogene       Date:  1996-01-04       Impact factor: 9.867
View more
  9 in total

1.  Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity.

Authors:  Yuki Kagoya; Akihide Yoshimi; Keisuke Kataoka; Masahiro Nakagawa; Keiki Kumano; Shunya Arai; Hiroshi Kobayashi; Taku Saito; Yoichiro Iwakura; Mineo Kurokawa
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

Review 2.  Inflammation meets cancer, with NF-κB as the matchmaker.

Authors:  Yinon Ben-Neriah; Michael Karin
Journal:  Nat Immunol       Date:  2011-07-19       Impact factor: 25.606

Review 3.  Apoptosis and epithelial injury in the lungs.

Authors:  Thomas R Martin; Naoki Hagimoto; Morio Nakamura; Gustavo Matute-Bello
Journal:  Proc Am Thorac Soc       Date:  2005

4.  A role of fas-associated death domain (FADD) in increased apoptosis in aged humans.

Authors:  Sudhir Gupta; Choong Kim; Leman Yel; Sastry Gollapudi
Journal:  J Clin Immunol       Date:  2004-01       Impact factor: 8.317

Review 5.  Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells.

Authors:  Shayda Hemmati; Tamanna Haque; Kira Gritsman
Journal:  Front Oncol       Date:  2017-11-13       Impact factor: 6.244

6.  IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts.

Authors:  Carrie D House; Valentina Grajales; Michelle Ozaki; Elizabeth Jordan; Helmae Wubneh; Danielle C Kimble; Jana M James; Marianne K Kim; Christina M Annunziata
Journal:  BMC Cancer       Date:  2018-05-25       Impact factor: 4.430

7.  Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.

Authors:  Jingxuan Shan; Aziz Chouchane; Younes Mokrab; Mohamad Saad; Salha Boujassoum; Rosalyn W Sayaman; Elad Ziv; Noureddine Bouaouina; Yasmine Remadi; Sallouha Gabbouj; Jessica Roelands; Xiaojing Ma; Davide Bedognetti; Lotfi Chouchane
Journal:  Front Oncol       Date:  2019-12-06       Impact factor: 6.244

8.  Peritumoural adipose tissue pro-inflammatory cytokines are associated with tumoural growth factors in cancer cachexia patients.

Authors:  Nelson Inácio Pinto Neto; Ariene Soares de Pinho Murari; Lila Missae Oyama; José Pinhata Otoch; Paulo Sérgio Martins Alcântara; Flavio Tokeshi; Raquel Galvão Figuerêdo; Michele Joana Alves; Joanna Darck Carola Correia Lima; Emídio Marques de Matos-Neto; Marilia Seelaender; Claudia Maria Oller do Nascimento
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-10-03       Impact factor: 12.910

9.  ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma.

Authors:  Bo Han; Xiangqi Meng; Pengfei Wu; Ziwei Li; Siyi Li; Yangong Zhang; Caijun Zha; Qile Ye; Chuanlu Jiang; Jinquan Cai; Tao Jiang
Journal:  Theranostics       Date:  2020-02-10       Impact factor: 11.556
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.